Professor Park Geun-chil from the Department of Hematology and Oncology leads the Lung Cancer Center composed of a coordinator and specialists from the Department of Hematology and Oncology, Department of Pulmonary, Department of Thoracic and Cardiovascular Surgery, Department of Radiation Oncology, Department of Radiation, Department of Pathology and Department of Nuclear Medicine.
Our Lung Cancer Center is applying the latest treatment and examination techniques in each field, such as diagnosis, testing, surgery, chemotherapy and radiation therapy, etc. Through sufficient inter-departmental conferences, our medical team is establishing the standardized practice guidelines and developing new treatments. Lung Cancer Center is making continuous efforts to be the leader of lung cancer treatment together with providing prompt and appropriate service to our patients.
For patients to whom application of the standardized practice guidelines is difficult, specialists from each field discuss and determine the best treatments for each patient through case conferences twice a week. As such, the strongest point of the Lung Cancer Center is the teamwork among the members. Moreover, the system of organic cooperation to provide accurate diagnoses and the best treatments for cancer patients helps them immeasurably.

Recently, we are actively administering 100 cases or more of thoracoscopic lobotomy per year on phase 1 patients. Also, by developing and introducing chemotherapy to improve the effects of treatment and to minimize side effects, we are paying attention not only to the results of treatment, but also to improving the quality of life for our patients. We are actively participating in clinical studies conducted both at home and abroad. This helps us provide the cancer patients with opportunities to receive the latest in chemotherapy treatment methods. In addition, we are activating the outpatient center to minimize the waiting time to receive chemotherapy.

Lung Cancer Center is introducing the techniques to cure lung cancer without surgical operations, such as endoscopic operation or 3D radiation therapy, etc. For early detection and accurate diagnosis of lung cancer, we administer the high-tech testing of PET-CT and low-dose helical CT scan, etc.

For the operable stage-1 lung cancer patients, the coordinator organizes our operation flow under cooperation with the ward, testing lab and the administration office so that the process from hospitalization to diagnosis and surgery is completed in the quickest time possible.

Ultimately, the Lung Cancer Center is aiming to increase the efficiency of our operation flow and to promote multidisciplinary approaches to maximize synergy in order to overcome this fatal disease with high mortality rates.